The global diabetes drugs market was valued at $79.3 billion in 2023, and is projected to reach $157.9 billion by 2033, growing at a CAGR of 7.1% from 2024 to 2033.
Report Code : A01159 | Pages : 280 | Category : Life Sciences
The global antiemetics market was valued at $2.3 billion in 2021, and is projected to reach $4.1 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031.
Report Code : A00336 | Pages : 260 | Category : Life Sciences
The global antipsychotic drugs market size was valued at $12,417.60 million in 2020, and is estimated to reach $26,041.00 million by 2030, growing at a CAGR of 8.0% ...
Report Code : A00338 | Pages : 187 | Category : Life Sciences
The global cancer therapeutics market size was valued at $98,900 million in 2018 and is estimated to reach at $180,193 million by 2026, registering a CAGR of 7.7% from 2019 to 2026. Cancer therapeutics involves the use and administration of chemotherapy and oncology drugs to treat cancer.
Report Code : A00381 | Pages : 261 | Category : Life Sciences
Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) ...
Report Code : A00402 | Pages : 55 | Category : Life Sciences
The global non small cell lung cancer market was valued at $15.3 billion in 2021, and is projected to reach $36.9 billion by 2031, growing at a CAGR of 9.3% from 2022 to 2031.
Report Code : A00544 | Pages : 262 | Category : Life Sciences
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in ...
Report Code : A00568 | Pages : 122 | Category : Life Sciences
The global vaccine adjuvants market was valued at $820.2 million in 2023, and is projected to reach $1,304.83 million by 2035, growing at a CAGR of 3.9% from 2024 to 2035.
Report Code : A01341 | Pages : 339 | Category : Life Sciences
The global pharmaceutical packaging market was valued at $111.7 billion in 2023, and is projected to reach $233.3 billion by 2035, growing at a CAGR of 6.3% from 2024 to 2035.
Report Code : A01501 | Pages : 275 | Category : Life Sciences
The global netupitant“palonosetron FDC market accounted for $257,162 million in 2015, and is estimated to reach $527,187 million by 2022, growing at a CAGR of 10.8% during the ...
Report Code : A01502 | Pages : 40 | Category : Life Sciences
LAMEA Oncology/Anti-cancer Drugs Market is expected to reach $17,072.2 million by 2021, registering a CAGR of 8.6% during the forecast period 2015 - 2021. Oncology drugs are used ...
Report Code : A00719 | Pages : 108 | Category : Life Sciences
The global empty capsules market size was valued at $2,382.7 million in 2020, and is projected to reach $5,230.4 million by 2030, registering a CAGR of 8.1% from ...
Report Code : A00835 | Pages : 290 | Category : Life Sciences
Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients ...
Report Code : A00899 | Pages : 116 | Category : Life Sciences
The global nuclear medicine market was valued at $5.5 billion in 2023, and is projected to reach $16.1 Billion by 2033, growing at a CAGR of 11.3% from 2024 to 2033
Report Code : A00971 | Pages : 260 | Category : Life Sciences
An influenza vaccine is a vaccine designed to protect against the influenza virus, commonly known as the flu, which comes in trivalent or quadrivalent types, used to treat seasonal and pandemic flu. It is based on egg-based and cell-based technology, used for adults and pediatric as well.
Report Code : A01118 | Pages : 217 | Category : Life Sciences
The global male hypogonadism market was valued at $3.1 billion in 2020, and is projected to reach $5.1 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030.
Report Code : A01544 | Pages : 150 | Category : Life Sciences
Global Potential Analysis of Human DNA Vaccines Market is expected to account for $3,762 million in 2020 and reach $9,337 million by 2030, by growing at a CAGR of 9.5% during the period, 2020 - 2030.
Report Code : A01978 | Pages : 120 | Category : Life Sciences
The global api intermediate market was valued at $139.4 billion in 2022, and is projected to reach $285 billion by 2032, growing at a CAGR of 7.4% from 2023 to 2032.
Report Code : A02308 | Pages : 390 | Category : Life Sciences
The global multiple sclerosis therapies market size was valued at $22.99 million in 2018, and is projected to reach $28.00 million by 2026, registering a CAGR of 2.5% ...
Report Code : A01119 | Pages : 151 | Category : Life Sciences
The global leukemia therapeutics market size was valued at $7,818.63 million in 2021 and is estimated to reach $14,162.48 million by 2031, exhibiting a CAGR of 6.1% from 2022 to 2031.
Report Code : A01128 | Pages : 392 | Category : Life Sciences
The lymphoma therapeutics market was valued at $15,691.45 million in 2022 and is projected to reach $35,207.45 million by 2032, registering a CAGR of 8.4% from 2023 to 2032.
Report Code : A01129 | Pages : 481 | Category : Life Sciences
The global cancer vaccines market was valued at $4,188 million in 2019, and is projected to reach $7,303 million by 2027, registering a CAGR of 12.6% from 2020 to 2027.
Report Code : A01134 | Pages : 284 | Category : Life Sciences
Antibody Drug Conjugates Market are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. ADC™s are designed to eliminate cancer cells only without harming the ...
Report Code : A01148 | Pages : 152 | Category : Life Sciences
The global pregabalin market was valued at $1.6 billion in 2022, and is projected to reach $2.2 billion by 2032, growing at a CAGR of 3% from 2023 to 2032.
Report Code : A02320 | Pages : 289 | Category : Life Sciences
The global prostate cancer treatment market size was valued at $6,887 million in 2018, and is projected to reach $9,904 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Report Code : A02321 | Pages : 188 | Category : Life Sciences
